WASHINGTON — Infant formula maker Abbott says it's reached an agreement with U.S. health officials to restart production at its largest domestic factory, a key step toward easing a nationwide shortage tied to the plant’s shutdown earlier this year.
Abbott, baby formula maker, says agreement reached to reopen plant
→
For its part, Abbott says its formula “is not likely the source of infection,” though the FDA says its investigation continues.
Parents hunting for baby formula as shortage spans U.S.
→